Work

A phase II study of weekly paclitaxel, lenvatinib and pembrolizumab among patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal cancer

Year: 2024

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2024.07.112

Authors: Floor Backes, Lai Wei, Casey Cosgrove, Kristin Bixel, Christa Nagel, Laura Chambers, David Cohn, Larry Copeland, John Hays, Sarah Crafton, Callan Myerscough, Molly Herman, David O'Malley

Institutions: The Ohio State University, Allegheny Health Network

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403250757

FWCI: 0.789

Cites:

Cited by: 2

Related to: 10